Literature DB >> 19586080

Pharmaceutical risk-sharing agreements.

Afschin Gandjour.   

Abstract

Mesh：

Year:  2009        PMID： 19586080     DOI： 10.2165/00019053-200927050-00007

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  4 in total

1.  Cost-effectiveness analysis with risk aversion.

Authors:  J G Zivin
Journal:  Health Econ       Date:  2001-09       Impact factor: 3.046

2.  Optimal allocation of resources over health care programmes: dealing with decreasing marginal utility and uncertainty.

Authors:  Maiwenn J Al; Talitha L Feenstra; Ben A van Hout
Journal:  Health Econ       Date:  2005-07       Impact factor: 3.046

3.  Risk-sharing agreements for innovative drugs: a new solution to old problems?

Authors:  Gérard de Pouvourville
Journal:  Eur J Health Econ       Date:  2006-09

4.  Pharmaceutical risk-sharing agreements.

Authors:  Joseph P Cook; John A Vernon; Richard Manning
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981
  4 in total
  2 in total

1.  Comment on: "Healthy Decisions: Towards Uncertainty Tolerance in Healthcare Policy".

Authors:  Afschin Gandjour
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

Review 2.  The Use of Risk-Sharing Contracts in Healthcare: Theoretical and Empirical Assessments.

Authors:  Fernando Antonanzas; Carmelo Juárez-Castelló; Reyes Lorente; Roberto Rodríguez-Ibeas
Journal:  Pharmacoeconomics       Date:  2019-12       Impact factor: 4.981
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.